1. Home
  2. DDL vs EOLS Comparison

DDL vs EOLS Comparison

Compare DDL & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DDL
  • EOLS
  • Stock Information
  • Founded
  • DDL 2014
  • EOLS 2012
  • Country
  • DDL China
  • EOLS United States
  • Employees
  • DDL N/A
  • EOLS N/A
  • Industry
  • DDL Catalog/Specialty Distribution
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • DDL Consumer Discretionary
  • EOLS Health Care
  • Exchange
  • DDL Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • DDL 446.5M
  • EOLS 493.5M
  • IPO Year
  • DDL 2021
  • EOLS 2018
  • Fundamental
  • Price
  • DDL $2.20
  • EOLS $7.19
  • Analyst Decision
  • DDL
  • EOLS Strong Buy
  • Analyst Count
  • DDL 0
  • EOLS 5
  • Target Price
  • DDL N/A
  • EOLS $21.25
  • AVG Volume (30 Days)
  • DDL 677.3K
  • EOLS 899.1K
  • Earning Date
  • DDL 11-05-2025
  • EOLS 11-05-2025
  • Dividend Yield
  • DDL N/A
  • EOLS N/A
  • EPS Growth
  • DDL 372.99
  • EOLS N/A
  • EPS
  • DDL 0.21
  • EOLS N/A
  • Revenue
  • DDL $3,335,962,059.00
  • EOLS $277,941,000.00
  • Revenue This Year
  • DDL $8.90
  • EOLS $14.01
  • Revenue Next Year
  • DDL $11.39
  • EOLS $29.46
  • P/E Ratio
  • DDL $10.63
  • EOLS N/A
  • Revenue Growth
  • DDL 15.14
  • EOLS 17.15
  • 52 Week Low
  • DDL $1.95
  • EOLS $5.71
  • 52 Week High
  • DDL $4.79
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • DDL 51.20
  • EOLS 42.33
  • Support Level
  • DDL $2.13
  • EOLS $7.19
  • Resistance Level
  • DDL $2.28
  • EOLS $7.75
  • Average True Range (ATR)
  • DDL 0.09
  • EOLS 0.31
  • MACD
  • DDL 0.01
  • EOLS 0.05
  • Stochastic Oscillator
  • DDL 60.00
  • EOLS 0.65

About DDL Dingdong (Cayman) Limited (each two representing three)

Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: